StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
Finnhub hasn't published the next scheduled earnings date yet. The list typically populates 4–8 weeks before the call.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-11 | $45.90 | $43.73 | -4.73% | 0.3M |
| 05-12 | $43.63 | $43.50 | -0.30% | 0.3M |
| 05-13 | $43.40 | $42.01 | -3.20% | 0.5M |
| 05-14 | $42.51 | $42.92 | +0.96% | 0.2M |
| 05-15 | $42.05 | $42.11 | +0.14% | 0.3M |
Earnings (▲ beat / ▼ miss) and ex-dividend dates plotted on the price line. Educational — proximity does not establish causation.
Past 1 reported quarters: EPS surprise vs estimate and the day-after-release stock reaction. Past performance does not predict future moves.
Sources: Finnhub earnings calendar + Polygon daily aggregates. Reaction direction can diverge from EPS surprise (guidance, macro, or sector flow can dominate the next-day print).
Each factor shows SCSC's percentile within the scored universe — observational ranking, not a recommendation.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
These are published opinions from external sell-side analysts — not Stonvex recommendations. Ratings may change without notice, may conflict with each other, and may be wrong. Not investment advice.
Consensus aggregated from publicly disclosed sell-side analyst ratings. Stonvex is not a registered investment advisor and does not endorse any of the ratings shown. Past analyst ratings do not predict future price movements.
ScanSource Inc provides value-added services for technology manufacturers and sells to resellers in specialty technology markets. The firm's operations are organized in two segments: Specialty Technology Solutions and Intelisys & Advisory Segment. It generates maximum revenue from the Specialty Technology Solutions segment. The Specialty Technology Solutions segment includes the company's business in mobility and barcode, POS, payments, security and networking technologies. Geographically, it derives a majority of revenue from the United States and Canada, and also has its presence in Brazil, and other countries.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.27B | $1.51B | $739.65M | $3.04B |
Operating Income | $66.89M | $43.77M | $25.90M | $85.20M |
Net Income | $53.26M | $16.49M | $19.88M | $71.55M |
EPS (Diluted) | $2.42 | $1.63 | $0.89 | $3.00 |
Total Assets | $1.81B | $1.74B | $1.72B | $1.79B |
Total Liabilities | $899.50M | $830.78M | $802.94M | $879.20M |
Cash & Equivalents | $120.30M | $83.47M | $124.92M | $126.16M |
Free Cash Flow OCF − CapEx | $118.63M | $49.68M | $20.82M | $104.06M |
Shares Outstanding | 20.78M | 21.65M | 22.07M | 22.22M |
What you need to know right now
This is an algorithmic assessment of current technical conditions, not investment advice. Past performance does not guarantee future results.
SCSC is in the extended universe. We surface dollar-volume + price-change percentiles for every US-listed name, but the full 6-factor DNA breakdown (momentum, news, sentiment, flow, relative strength) is only computed on the curated 1138-name primary list.
DNA analysis is not available for this ticker.